SYRE icon

Spyre Therapeutics
SYRE

Overview Fund Activity

26 hedge funds and large institutions have $24.4M invested in Spyre Therapeutics in 2016 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
26
Holders Change
-2
Holders Change %
-7.14%
% of All Funds
0.65%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
4
Increased
7
Reduced
4
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
$239K
2
SCM
Sio Capital Management
New York
$820K
3
Jennison Associates
Jennison Associates
New York
$6.29M
4
Wells Fargo
Wells Fargo
California
$75K
5
SIM
Spark Investment Management
New York
$52K

Top Sellers

1
RCM
RA Capital Management
Massachusetts
$0
2
GTC
Ghost Tree Capital
New York
$0
3
Millennium Management
Millennium Management
New York
$0
4
Goldman Sachs
Goldman Sachs
New York
$45K
5
TG
TLP Group
Illinois
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
RCM
26
RA Capital Management
Massachusetts
– -$2.16M -13,445 Closed
GTC
27
Ghost Tree Capital
New York
– -$321K -2,000 Closed
Millennium Management
28
Millennium Management
New York
– -$230K -1,438 Closed
TG
29
TLP Group
Illinois
– -$76K -477 Closed
CS
30
Credit Suisse
Switzerland
– -$64K -400 Closed
Bank of America
31
Bank of America
North Carolina
– -$3K -18 Closed
1
2